Architecture Artificial Intelligence Pharmaceuticals 
CIO Business Intelligence
OCTOBER 13, 2023
The data architect also “provides a standard common business vocabulary, expresses strategic requirements, outlines high-level integrated designs to meet those requirements, and aligns with enterprise strategy and related business architecture,” according to DAMA International’s Data Management Body of Knowledge.
CIO Business Intelligence
JULY 18, 2023
Nvidia’s transformation from an accelerator of video games to an enabler of artificial intelligence (AI) and the industrial metaverse didn’t happen overnight—but the leap in its stock market value to over a trillion dollars did. Nvidia says its hardware, software, and services can cut early-stage drug discovery from months to weeks.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO Business Intelligence
DECEMBER 14, 2023
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If Artificial Intelligence, Cloud Computing, IT Strategy, Risk Management Don’t companies have the same issue for data centers on-premise?
CIO Business Intelligence
DECEMBER 5, 2023
54% of IT Decision Makers also expect to use cloud capabilities to leverage Artificial Intelligence (AI)/Machine Learning (ML) over the next year, which many see as a potential game changer for their industries. However, EMEA organisations are facing challenges in their digital and cloud journeys.
CIO Business Intelligence
MARCH 2, 2023
As an example, the technology organization of the pharmaceutical segment at Cardinal Health collaborates closely with business leaders so they can identify current pain points and determine the right processes to automate, focusing on how these tools will improve the customer or employee experiences, says CIO Greg Boggs. “In
CIO Business Intelligence
AUGUST 18, 2022
The giant pharmaceutical chain had put its lakehouse in place to address just such challenges in its quest, to, as Guadagno puts it, “To get the right product in the right place for the right patient.”. Using Apache Ignite technology from GridGain, Wiesenfeld created an in-memory computing architecture.
CIO Business Intelligence
MARCH 21, 2023
Nvidia is targeting it at pharmaceutical firms for drug discovery and testing, fine-tuning it with proprietary data. Having Nvidia as a service provider will likely mean a single source of responsibility for the service and a familiar underlying solution architecture,” he said.
Expert insights. Personalized for you.
132 
Let's personalize your content